Electronic Imaging Materials

Check out what our happy lab clients have to say about us! hubs.la/Q031KwFh0

With genes like these, it’s only natural we make DNA puns!🧬Happy DNA Day to all the GENE-iuses out there making discoveries!

@SciTechera Can I get one of those mechanical arms to help around the house?

Thats amazing. Medra’s Lab 001 is the largest autonomous labs in the U.S., where AI does not just assist research… it actually runs it. This new system designs experiments, executes them with robotic equipment, analyzes results, and improves the next step all on its own. The lab runs 24/7, turning biology into a continuous learning loop instead of slow, manual trial-and-error.

@dartmouth An incredible achievement at such a young age! Always exciting to see the next generation’s curiosity being recognized and supported at this level. That’s how research moves forward.

The encryption protecting your texts relies on math problems so challenging that they’re nearly impossible to crack. Benjamin Singer ‘27 has earned a Goldwater Scholarship to study them—and he's writing a reference book on the subject as his senior thesis. bit.ly/4sTDWHU

Some handwriting belongs on a card, not on a sample. 🧪 Preprinted labels bring the clarity and consistency your lab needs to keep things running smoothly. Save time and mental energy by taking the guesswork out of sample identification! ➡️ Visit hubs.la/Q049gXdd0

@MayoClinic We’re all so unique, which is why care should never be one-size-fits-all. Personalized approaches, especially with tools like AI, feel like an important step toward more targeted support for issues like chronic pain.

People worldwide seek medical care for back and neck pain, which can interfere with sleep, mobility and daily life. For individuals who need surgery for spinal conditions, advances in robotics, artificial intelligence (AI) and motion-preserving implants are expanding treatment options and allowing for more personalized treatment, according to Ahmad Nassr, M.D., orthopedic surgeon at Mayo Clinic. Learn more: mayocl.in/4cBZuTa

@fascinatingonX Shortages would be no more with this! And no testing needed for compatibility? Almost sounds too good to be true. This is revolutionary news.🩸

🚨HUGE NEWS: Japanese researchers from National Defence Medical College have created ARTIFICIAL BLOOD that could be compatible with any blood type.

@NewsfromScience Nano bots, roll out! 🤖

The better humans have gotten at making plastic, the more challenging it has been to unmake it—especially the pieces too small to see. Long after plastic bottles and bags break down, they keep fragmenting into particles so tiny, conventional filtration can’t touch them. They drift through treatment plants and into waterways unimpeded. There, they enter the food chain, and ultimately the body, where they have been found in human organs and are increasingly linked to various diseases such as cancer. Enter nanobots. In a new study, researchers show that tiny magnetic machines made of cagelike materials can tumble through water, sweeping up nanoplastics via the same electrostatic attraction that makes a balloon cling to your hair. Learn more: scim.ag/4cnM9iB

Nano bots, roll out! It’s amazing that something as simple as static electricity, like a balloon pulling your hair, can be used at the microscopic scale to capture nanoplastics. #Science

@forallcurious Me trying to find who stole my favorite office chair:

White blood cell wandering between red blood cells and looking for harmful organisms!

@MIT What a clever solution to a problem that once seemed unsolvable - reprogramming a cell to better fight disease. Incredible work by all involved!

As people age, their immune system function declines. T cell populations decline and can’t react to pathogens as quickly, making people more susceptible to infections. To try to overcome that decline, researchers at MIT and the Broad Institute have found a way to temporarily program cells in the liver to improve T-cell function. news.mit.edu/2025/new-study…

Shoutout to the lab pros keeping the research goin', one sample at a time! 😎 We’re proud to serve your industry with labels that stick… so your discoveries don’t get lost in the mix. #LabWeek #WorldLaboratoryDay #Science

Labels for cryogenic applications are in high demand at many labs across the globe. Labels that can withstand temps as low as -196°C are anything but ordinary. Need help with your deep freeze operations? Check out our CryoLabel® product line and order your free samples today!

@ScienceMagazine Strong progress here. Huge effort behind the scenes to bring a discovery like this to life.

For decades, biology textbooks have enshrined a simple rule: DNA is made by copying a template. After one enzyme unzips a DNA double helix into separate strands, another called a polymerase builds a complementary sequence, base by base, for each strand. Presto: two copies of the original DNA. But new research into how bacteria defend themselves from viruses now shows this synthesis rule isn’t absolute. Now, a team describes a bacterial enzyme that synthesizes DNA without a nucleic acid template, using its own structure as a guide. Learn more: scim.ag/4tTc5IA @NewsfromScience

@twibuznew There are battles happening so close to us and we don't even realize it!

More new discoveries dropping in the clinical trials sector! Thanks to advancements in drug research, we’re able to develop processes that are more targeted, more predictive, and closer to real human biology than ever before. 🧬🧫

@joseramosvivas Really important shift. As drug discovery becomes more human-centered and data-driven, the physical side of research matters just as much. Add AI to the mix, and results are set to become faster and more precise!

¿Sabías que cerca del 90% de los fármacos que llegan a ensayos clínicos fallan, en parte porque los modelos animales no predicen bien la respuesta humana? 🐁❌ ¿Es hora de un cambio de paradigma? Un nuevo artículo en Cell analiza las Nuevas Metodologías de Enfoque (NAMs): una revolución humanocéntrica en el descubrimiento de fármacos. 🧬💊 Lo más destacado: 🧫 Organoides e iPSCs: Mini-órganos y células madre humanas para modelar enfermedades con una precisión mucho más cercana a la fisiología real. 🤖 IA e In Silico: Plataformas de inteligencia artificial capaces de predecir toxicidad y eficacia antes de entrar al laboratorio. ⚖️ Marco legal: Las Actas de Modernización de la FDA (1.0 a 3.0) abren la puerta a sustituir pruebas animales por modelos humanos y digitales, impulsando una nueva era regulatoria. 🚀 Objetivo: Reducir el enorme fracaso clínico y acelerar la llegada de terapias seguras y eficaces a los pacientes. 🏥 ¿Estamos ante el fin de una era y el inicio de una medicina más ética, precisa y eficiente? 🌍✨ 🔗👇💊 doi.org/10.1016/j.cell… Ciencia #Farmacología #IA #BioTech #Salud #Innovación #NAMs #StemCells #CellPress #Cell @SEMicrobiologia @ANIH_1

@dqveed He'll never have to pay for a meal again👏

Listen, if we get to a point where pancreatic cancer is no longer an issue… give this man whatever he wants. Every medal…

Uplifting #Science News Monday!🧪 Promising results are in, and it looks like we're ever so closer to finding a cure for #pancreaticcancer. According to the results, <13% of patients survive 5 years after administration of the vaccine – and those numbers will continue improving.

@BoWang87 Incredible work from all teams involved. Inching closer and closer to finding a cure!🧪

Pancreatic cancer has one of the most suppressive tumor microenvironments in oncology. But two pancreatic cancer results dropped today. Both matter. 1. BioNTech mRNA neoantigen vaccine: nearly all responders still alive at 6 years. 98% of induced T cells were de novo — the immune system learned to see a cancer it had always been blind to. 2. Daraxonrasib: 47% ORR, 92% disease control as first-line monotherapy. KRAS G12D, undruggable for 40 years, finally has a drug. Different mechanisms. Same disease. Both working. <13% of patients survive 5 years. That number is about to change. great day for science! 🔥